The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Final data from CALM: A phase II study of Coxsackievirus A21 (CVA21) oncolytic virus immunotherapy in patients with advanced melanoma.
 
Robert Hans Ingemar Andtbacka
Consulting or Advisory Role - Amgen
Speakers' Bureau - Novartis
Research Funding - Amgen (Inst); Viralytics (Inst)
 
Brendan D. Curti
Honoraria - Prometheus
Research Funding - Bristol-Myers Squibb (Inst); MedImmune (Inst); Prometheus (Inst)
Travel, Accommodations, Expenses - Agonox; Prometheus
 
Howard Kaufman
Consulting or Advisory Role - Alkermes; Amgen; Merck; Merck Serono; Prometheus
Research Funding - Bristol-Myers Squibb/Medarex
 
Gregory A. Daniels
Patents, Royalties, Other Intellectual Property - UC San Diego (Inst)
Other Relationship - Prometheus
 
John J. Nemunaitis
No Relationships to Disclose
 
Lynn E. Spitler
Speakers' Bureau - Genentech
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); Cosmo Biosciences (Inst); GlaxoSmithKline (Inst); Merck (Inst); Polynoma (Inst); Viralytics (Inst)
 
Sigrun Hallmeyer
No Relationships to Disclose
 
Jose Lutzky
Honoraria - Bristol-Myers Squibb; Genentech/Roche
Speakers' Bureau - Bristol-Myers Squibb; Genentech/Roche
Research Funding - Amgen; AstraZeneca/MedImmune; Bristol-Myers Squibb; Genentech/Roche; GlaxoSmithKline; Incyte; Merck; Merck Serono; Millennium; Novartis; Onconova Therapeutics; Prometheus; Viralytics
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Bristol-Myers Squibb; Genentech/Roche; Prometheus
 
Stephen Michael Schultz
No Relationships to Disclose
 
Eric D. Whitman
No Relationships to Disclose
 
Karl Zhou
No Relationships to Disclose
 
Roberta Karpathy
Employment - Viralytics
Leadership - Viralytics
Stock and Other Ownership Interests - Viralytics
Patents, Royalties, Other Intellectual Property - Viralytics
Travel, Accommodations, Expenses - Viralytics
 
Jeffrey Ira Weisberg
Employment - Viralytics
Leadership - Viralytics
Stock and Other Ownership Interests - Viralytics
Consulting or Advisory Role - Viralytics
Travel, Accommodations, Expenses - Viralytics
 
Mark Grose
Employment - Viralytics
Stock and Other Ownership Interests - Viralytics
Consulting or Advisory Role - Viralytics
Travel, Accommodations, Expenses - Viralytics
 
Darren Shafren
Employment - Viralytics
Leadership - Viralytics
Stock and Other Ownership Interests - Viralytics
Consulting or Advisory Role - Viralytics
Research Funding - Viralytics
Patents, Royalties, Other Intellectual Property - Viralytics
Travel, Accommodations, Expenses - Viralytics